deltatrials
Recruiting NA INTERVENTIONAL 1-arm NCT05171205

Spinal Cord Stimulation for Parkinsonism (SCS for PDS)

Spinal Cord Stimulation for Parkinsonism: a Single-center, Single-arm Open Trial

Sponsor: Ruijin Hospital

Conditions Parkinsonism
Updated 8 times since 2022 Last updated: May 5, 2025 Started: May 1, 2021 Primary completion: Dec 31, 2026 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Parkinsonism and is currently actively recruiting participants. Ruijin Hospital leads this study, which shows 8 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2022 – ~Feb 2022 · 31 days · monthly snapshotRecruiting~Feb 2022 – ~Dec 2022 · 10 months · monthly snapshotRecruiting~Dec 2022 – ~Dec 2023 · 12 months · monthly snapshotRecruiting~Dec 2023 – ~Jan 2024 · 31 days · monthly snapshotUnknown Status~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshotRecruiting~Jun 2025 – present · 15 months · monthly snapshotRecruiting

Change History

8 versions recorded
  1. Jun 2025 — Present [monthly]

    Recruiting NA

  2. Sep 2024 — Jun 2025 [monthly]

    Recruiting NA

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  4. Jan 2024 — Jul 2024 [monthly]

    Recruiting NA

    Status: Unknown StatusRecruiting

  5. Dec 2023 — Jan 2024 [monthly]

    Unknown Status NA

    Status: RecruitingUnknown Status

Show 3 earlier versions
  1. Dec 2022 — Dec 2023 [monthly]

    Recruiting NA

  2. Feb 2022 — Dec 2022 [monthly]

    Recruiting NA

  3. Jan 2022 — Feb 2022 [monthly]

    Recruiting NA

    First recorded

May 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ruijin Hospital
Data source: Ruijin Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations